These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 18006853

  • 1. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR.
    Cancer Res; 2007 Nov 15; 67(22):11064-73. PubMed ID: 18006853
    [Abstract] [Full Text] [Related]

  • 2. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R.
    Oncogene; 2004 Apr 08; 23(15):2672-2680. PubMed ID: 14755243
    [Abstract] [Full Text] [Related]

  • 3. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
    Hsu YM, Chou CY, Chen HH, Lee WY, Chen YF, Lin PW, Alper SL, Ellory JC, Shen MR.
    J Cell Physiol; 2007 Mar 08; 210(3):626-36. PubMed ID: 17133354
    [Abstract] [Full Text] [Related]

  • 4. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A, Rosanò L.
    Cells Tissues Organs; 2007 Mar 08; 185(1-3):85-94. PubMed ID: 17587812
    [Abstract] [Full Text] [Related]

  • 5. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.
    Exp Cell Res; 2007 Jan 15; 313(2):380-93. PubMed ID: 17141758
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the stability of cell surface E-cadherin by the proteasome.
    Saitoh M, Shirakihara T, Miyazono K.
    Biochem Biophys Res Commun; 2009 Apr 17; 381(4):560-5. PubMed ID: 19245796
    [Abstract] [Full Text] [Related]

  • 7. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 17; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F, Behrens J.
    Exp Cell Res; 2006 Feb 15; 312(4):457-67. PubMed ID: 16368435
    [Abstract] [Full Text] [Related]

  • 9. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W, Jiang B, Guo Z, Sardet C, Zou B, Lam CS, Li J, He M, Lan HY, Pang R, Hung IF, Tan VP, Wang J, Wong BC.
    Carcinogenesis; 2010 Jul 15; 31(7):1220-9. PubMed ID: 20460358
    [Abstract] [Full Text] [Related]

  • 10. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [Abstract] [Full Text] [Related]

  • 11. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ.
    Chin Med J (Engl); 2004 Aug 15; 117(8):1232-9. PubMed ID: 15361301
    [Abstract] [Full Text] [Related]

  • 12. E-cadherin regulates the association between beta-catenin and actinin-4.
    Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T.
    Cancer Res; 2005 Oct 01; 65(19):8836-45. PubMed ID: 16204054
    [Abstract] [Full Text] [Related]

  • 13. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
    Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB.
    Cancer Res; 2006 Dec 01; 66(23):11370-80. PubMed ID: 17145883
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
    Yuan Z, Wong S, Borrelli A, Chung MA.
    Biochem Biophys Res Commun; 2007 Oct 26; 362(3):740-6. PubMed ID: 17764657
    [Abstract] [Full Text] [Related]

  • 15. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
    Lin CY, Lin CJ, Chen KH, Wu JC, Huang SH, Wang SM.
    FEBS Lett; 2006 May 29; 580(13):3042-50. PubMed ID: 16678166
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
    Kim K, Daniels KJ, Hay ED.
    Exp Cell Res; 1998 Nov 25; 245(1):79-90. PubMed ID: 9828103
    [Abstract] [Full Text] [Related]

  • 17. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.
    Int J Oncol; 2012 Jul 25; 41(1):211-8. PubMed ID: 22552741
    [Abstract] [Full Text] [Related]

  • 18. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L, Jullien L, Gire V, Roux P.
    J Cell Sci; 2010 Apr 15; 123(Pt 8):1295-305. PubMed ID: 20332115
    [Abstract] [Full Text] [Related]

  • 19. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G.
    Oncogene; 2007 Apr 05; 26(16):2290-8. PubMed ID: 17043652
    [Abstract] [Full Text] [Related]

  • 20. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC.
    Carcinogenesis; 2008 Feb 05; 29(2):252-62. PubMed ID: 17999987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.